Testing Procedures; Samples i. Contractor will conduct a PCR COVID-19 test collected via either (i) an Anterior Nares nasal swab that is self-administered by the participant unless the Contractor is directed otherwise; or (ii) a saliva sample. Samples will be processed in Contractor’s state-licensed lab, or partner lab if necessary. Test results will be available within 24 to 48-hours of test administration. In the event of an indeterminate test, Contractor will re process a participant’s test.
Testing Procedures; Samples. All samples for testing will be taken by appropriately qualified personnel. Urine specimens taken will be split into two samples. Each sample will be appropriately marked with the participant’s identification. Privacy To the greatest extent possible, the privacy of the participant will be preserved while the sample(s) to be tested are taken. However, some precautions will help to ensure that pure specimens are obtained. Screening The initial screening will be by immunoassay and require gas chromatography/mass spectrometry (GC/MS) for confirmation. Adulteration or Substitution An on-site Adulteration or Substitution of a specimen shall be treated as a positive test. If the laboratory is unable to analyze a sample (inadequate or dilute sample), the participant must take an additional test within 72 hours of receiving notice of such. Failure to submit an acceptable specimen as provided for herein will be treated as a positive test. If a specimen is out of temperature at the time of collection, the participant must give another sample within three (3) hours without leaving the collections facility, regardless of the type of test being conducted, e.g., random or annual. Failure to do so will be considered a refusal to test. Failure to submit an acceptable sample will be considered a positive test. Reports After the Medical Review Officer (MRO) review, reports shall be made in writing and sent to the Union and Employer DRs.
